Fosamax Femur Fracture Lawyers Should Name Numerous Causes of Action
Those who obtain a Fosamax femur fracture lawyer and sue a drugmaker over their abnormal thigh bone break, in an effort to maximize their chances of obtaining compensation, should consider naming as many legitimate causes of action as possible against blameworthy manufacturers.
Last month, a Louisiana woman filet suit against Merck Sharp & Dohme Corp. (formerly known as Merck & Co. Inc.), Watson Pharmaceuticals Inc., and Barr Laboratories Inc. in Louisiana federal court. According to the complaint of Josephine P. Naccio, she was allegedly prescribed Fosamax for osteoporosis treatment, which led to her suffering a femur fracture. Naccio makes a number of claims against drug manufacturers, including that they aggressively promoted Fosamax for non-approved uses, were not forthright about the risks of femur fractures, and failed to perform post-marketing surveillance. Nacccio maintains that had she known of the long-term health risks of Fosamax, she would not have taken the drug. Her suit names numerous causes of action against the defendants, including composition defect, design defect, inadequate warning, breach of express warranty, breach of express and implied warranty of fitness for ordinary use, and redhibition. The plaintiff is seeking numerous types of damages, including actual, treble and punitive, and interest in addition to court costs and attorney's fees.
The lawsuit is one of the most recent to be leveled against manufacturers of bisphosphonates, a class of drugs that includes Fosamax, after the publication of numerous studies that link the drugs to unusual femur breaks and the release of a U.S. Food and Drug Administration (FDA) warning in October. To date, 100 claims similar to Naccio's have been filed in federal courts throughout the country, with many more expected as lawyers nationwide continue to review and file claims against Merck and other drug manufacturers. Although Merck's patent for Fosamax expired in 2008, generic versions continue to be made by a number of companies.
By naming multiple, legitimate causes of action against drugmakers in a Fosamax lawsuit, claimants increase their chances of obtaining financial compensation. Keep in mind, however, that any viable femur fracture case against Merck or another manufacturer begins with the diagnosis of a thigh bone break, which can be obtained through a visit to one's physician. Once this has been done, the next step should be to consult with an attorney.
The Rottenstein Law Group is dedicated to assisting those who have been harmed by the medication Fosamax. Although dangerous side effects are not illegal in and of themselves, defectively designing a product and failing to properly warn of its side effects are. Merck has clearly acted recklessly in an effort to pad its bottom line, and if you suffered harm as a result, RLG wants to help you hold the company responsible. Our Fosamax femur fracture lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations like Merck.
Last month, a Louisiana woman filet suit against Merck Sharp & Dohme Corp. (formerly known as Merck & Co. Inc.), Watson Pharmaceuticals Inc., and Barr Laboratories Inc. in Louisiana federal court. According to the complaint of Josephine P. Naccio, she was allegedly prescribed Fosamax for osteoporosis treatment, which led to her suffering a femur fracture. Naccio makes a number of claims against drug manufacturers, including that they aggressively promoted Fosamax for non-approved uses, were not forthright about the risks of femur fractures, and failed to perform post-marketing surveillance. Nacccio maintains that had she known of the long-term health risks of Fosamax, she would not have taken the drug. Her suit names numerous causes of action against the defendants, including composition defect, design defect, inadequate warning, breach of express warranty, breach of express and implied warranty of fitness for ordinary use, and redhibition. The plaintiff is seeking numerous types of damages, including actual, treble and punitive, and interest in addition to court costs and attorney's fees.
The lawsuit is one of the most recent to be leveled against manufacturers of bisphosphonates, a class of drugs that includes Fosamax, after the publication of numerous studies that link the drugs to unusual femur breaks and the release of a U.S. Food and Drug Administration (FDA) warning in October. To date, 100 claims similar to Naccio's have been filed in federal courts throughout the country, with many more expected as lawyers nationwide continue to review and file claims against Merck and other drug manufacturers. Although Merck's patent for Fosamax expired in 2008, generic versions continue to be made by a number of companies.
By naming multiple, legitimate causes of action against drugmakers in a Fosamax lawsuit, claimants increase their chances of obtaining financial compensation. Keep in mind, however, that any viable femur fracture case against Merck or another manufacturer begins with the diagnosis of a thigh bone break, which can be obtained through a visit to one's physician. Once this has been done, the next step should be to consult with an attorney.
The Rottenstein Law Group is dedicated to assisting those who have been harmed by the medication Fosamax. Although dangerous side effects are not illegal in and of themselves, defectively designing a product and failing to properly warn of its side effects are. Merck has clearly acted recklessly in an effort to pad its bottom line, and if you suffered harm as a result, RLG wants to help you hold the company responsible. Our Fosamax femur fracture lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations like Merck.
Source...